USP31 serves as a potential biomarker for predicting prognosis and immune responses for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.
Yaoyu YuGuihua ChenChao JiangTuanjie GuoHeting TangZhihao YuanYi WangXiangyin TanJinyuan ChenEncheng ZhangXiang WangPublished in: The journal of gene medicine (2023)
USP31 could serve as a potential biomarker for predicting both prognosis and immune responses, revealing its potential mechanisms of TF-USP31 mRNA networks in ccRCC.